EUVIMEDEUVIMED entdecken
Querschnittstudie

Community pharmacist-and psychologist-led program of neuropsychological screening in the aftermath of the COVID-19 pandemic: A cross-sectional survey

Nicola Luigi BRAGAZZI, Fiorella PALOMBO-FERRETTI, Rocco CARBONE, Tania Simona RE, "Pharmacists- and Psychologists in community pharmacies-led Psychological Screening for Cognitive issues in the aftermath of the COVID-19 pandemic" (PsyChOVID) WORKING GROUP

Journal of Health and Social Sciences · 2023-06 · 8 (2) · 142-150

DOI: 10.19204/2023/cmmn6 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Health and Social Sciences, 2023-06. Verfasst von Nicola Luigi BRAGAZZI und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early detection and diagnosis of cognitive impairment are paramount to improving the clinical outcomes and care of patients. Whilst primary care professionals play a key role in the healthcare management and treatment of their patients, community pharmacists and other allied health professionals working in community pharmacies are more accessible and trusted. As such, they are in an ideal position to identify and assist in the management of individuals with cognitive memory disorders.

Aim

To assess the impact of a pharmacist-based cognitive memory screening service delivered in community pharmacy practice in Italy in the aftermath of the COVID-19 pandemic.

Design

Cross-sectional questionnaire-based survey.

Setting

Community pharmacies. Population: Patients accessing community pharmacies.

Methods

Participants underwent a comprehensive neuropsychological screening program (the “Montreal Cognitive Assessment” (MoCA) test, the “Babcock Story Recall Test”, and the “Rey–Osterrieth complex figure” (ROCF) test). The accuracy, sensitivity, and specificity of the classical medical/psychological referral for cognitive impairment were computed.

Results

A sample of 185 subjects (aged 61.24±15.06 years, 78.9% females) was recruited. The classical medical/psychological referral yielded an accuracy ranging from 58.4% to 63.2%, a sensitivity of 56.3-66.7%, and a specificity of 57.9-74.0% in terms of detection of individuals with cognitive impairment. The neuropsychological screening enabled the identification of a further 33.3-43.8% of subjects that would have been missed otherwise.

Conclusions

Neuropsychological screening programs in the setting of community pharmacies are highly valuable and effective.

Schlagwörter

cognitive impairmentcommunity pharmacycovid-19neuropsychological screening

Zitieren

APA

BRAGAZZI, N. L., PALOMBO-FERRETTI, F., CARBONE, R., RE, T. S., & GROUP, P. A. P. I. C. P. P. S. F. C. I. I. T. A. O. T. C. P. P. W. (2023). Community pharmacist-and psychologist-led program of neuropsychological screening in the aftermath of the COVID-19 pandemic: A cross-sectional survey. Journal of Health and Social Sciences, 8(2), 142-150. https://doi.org/10.19204/2023/cmmn6

Vancouver

BRAGAZZI NL, PALOMBO-FERRETTI F, CARBONE R, RE TS, GROUP PAPICPPSFCIITAOTCPPW. Community pharmacist-and psychologist-led program of neuropsychological screening in the aftermath of the COVID-19 pandemic: A cross-sectional survey. Journal of Health and Social Sciences. 2023;8(2):142-150. doi:10.19204/2023/cmmn6

BibTeX
@article{BRAGAZZI2023,
  author = {BRAGAZZI, Nicola Luigi and PALOMBO-FERRETTI, Fiorella and CARBONE, Rocco and RE, Tania Simona and GROUP, "Pharmacists- and Psychologists in community pharmacies-led Psychological Screening for Cognitive issues in the aftermath of the COVID-19 pandemic" (PsyChOVID) WORKING},
  title = {Community pharmacist-and psychologist-led program of neuropsychological screening in the aftermath of the COVID-19 pandemic: A cross-sectional survey},
  journal = {Journal of Health and Social Sciences},
  year = {2023},
  volume = {8},
  number = {2},
  pages = {142--150},
  doi = {10.19204/2023/cmmn6}
}
Kostenlos starten →